George Hampton
Direttore/Membro del Consiglio presso AMRYT PHARMA PLC
Posizioni attive di George Hampton
Società | Posizione | Inizio | Fine |
---|---|---|---|
AMRYT PHARMA PLC | Direttore/Membro del Consiglio | 24/09/2019 | - |
Currax Pharmaceuticals LLC
Currax Pharmaceuticals LLC Drugstore ChainsRetail Trade Currax Pharmaceuticals LLC engages in operation of a pharmaceutical business focused on acquiring and commercializing prescription drugs. It offers branded and generic products. The company is headquartered in Brentwood, TN. | Direttore/Membro del Consiglio | 01/04/2019 | - |
Amministratore Delegato | 01/04/2019 | - |
Storia della carriera di George Hampton
Precedenti posizioni note di George Hampton
Società | Posizione | Inizio | Fine |
---|---|---|---|
IMAC HOLDINGS, INC. | Direttore/Membro del Consiglio | 01/02/2019 | 21/10/2020 |
Independent Dir/Board Member | 01/02/2019 | 21/10/2020 | |
Horizon Pharmaceuticals, Inc.
Horizon Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Horizon Pharmaceuticals, Inc. is a pharmaceutical company that specializes in the development, manufacture, and lifecycle management of blow-fill-seal (BFS) technology and products for the pharmaceutical, medical device, diagnostic, and clinical industries. The private company is based in West Palm Beach, FL and operates two segments: blow-fill-seal drug discovery and development and blow-fill-seal manufacturing, including in-house mold fabrication. The company is a leader in custom BFS aseptic manufacturing and have the capabilities to complete projects at any stage of the development cycle. The company also holds a state license for the manufacture of pharmaceutical drugs (OTC and prescription) and medical devices. | Corporate Officer/Principal | 01/04/2015 | 01/10/2018 |
Global Village Concerns
Global Village Concerns Miscellaneous Commercial ServicesCommercial Services Global Village Concerns provides online social commerce services. The private company is based in San Diego. | Amministratore Delegato | 01/01/2009 | 01/02/2015 |
Presidente | 01/01/2009 | 01/02/2015 | |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Direttore/Membro del Consiglio | 25/09/2019 | - |
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Corporate Officer/Principal | 01/04/2015 | - |
Formazione di George Hampton
Miami University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 6 |
Regno Unito | 3 |
Irlanda | 2 |
Posizioni
Director/Board Member | 4 |
Corporate Officer/Principal | 2 |
Chief Executive Officer | 2 |
Settori
Health Technology | 5 |
Consumer Services | 2 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
IMAC HOLDINGS, INC. | Health Services |
Aziende private | 6 |
---|---|
Horizon Therapeutics Plc
Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
Horizon Pharmaceuticals, Inc.
Horizon Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Horizon Pharmaceuticals, Inc. is a pharmaceutical company that specializes in the development, manufacture, and lifecycle management of blow-fill-seal (BFS) technology and products for the pharmaceutical, medical device, diagnostic, and clinical industries. The private company is based in West Palm Beach, FL and operates two segments: blow-fill-seal drug discovery and development and blow-fill-seal manufacturing, including in-house mold fabrication. The company is a leader in custom BFS aseptic manufacturing and have the capabilities to complete projects at any stage of the development cycle. The company also holds a state license for the manufacture of pharmaceutical drugs (OTC and prescription) and medical devices. | Health Technology |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Health Technology |
Global Village Concerns
Global Village Concerns Miscellaneous Commercial ServicesCommercial Services Global Village Concerns provides online social commerce services. The private company is based in San Diego. | Commercial Services |
Currax Pharmaceuticals LLC
Currax Pharmaceuticals LLC Drugstore ChainsRetail Trade Currax Pharmaceuticals LLC engages in operation of a pharmaceutical business focused on acquiring and commercializing prescription drugs. It offers branded and generic products. The company is headquartered in Brentwood, TN. | Retail Trade |
Amryt Pharma Plc
Amryt Pharma Plc Pharmaceuticals: MajorHealth Technology Amryt Pharma Plc operates as a holding company with interests in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. The company was founded on July 17, 2019 and is headquartered in Dublin, Ireland. | Health Technology |
- Borsa valori
- Insiders
- George Hampton
- Esperienza